Nashville will soon be home to another health care corporate office following the announcement of a $165 million deal in the surgical instrument space.

Indiana-based Symmetry Medical on Monday said it will buy the instruments business of the Codman & Shurtleff division of Johnson & Johnson and merge it with its own instruments subsidiary. The combined venture, which will have about $100 million in revenue and a sales presence in 60 countries, will then be renamed Symmetry Surgical and relocate its headquarters to Nashville.

The scope of Symmetry Surgical’s future local base, including how many jobs it would bring here, is unclear. Symmetry bought a group of locally based surgical instrument companies in 2007, when those business had revenues of about $21 million. Based on Symmetry's Monday announcement, that number appears to have grown to $40 million since then.

"The acquisition achieves several strategic objectives for Symmetry, including diversification of our revenue base with higher margin, intellectual property-backed products that generate strong cash flow,” said Symmetry Medical President and CEO Thomas Sullivan, who also will lead Symmetry Surgical. “The acquired assets include a strategic capability in instrument procurement and add scale and a robust international presence to our hospital direct business.”

Symmetry Medical (Ticker: SMA) is based in Warsaw, Ind., and in the first nine months of this year, the company posted a profit of $6.1 million on revenues of $275 million.